Novartis to Acquire Breast Cancer Drug for $3 Billion
Novartis is set to acquire a breast cancer drug for approximately $3 billion, according to Bloomberg. This acquisition signals Novartis's continued investment in oncology and its commitment to developing treatments for cancer.